Evidence map›Paper›PMID 35264364›Full record

ArticleBMJ open2022

Prevalence of depression in China during the early stage of the COVID-19 pandemic: a cross-sectional study in an online survey sample.

Weina Liu, Fengyun Yu, Pascal Geldsetzer, Juntao Yang, Zhuoran Wang, Todd Golden, Lirui Jiao, Qiushi Chen, Haitao Liu, Peixin Wu and 3 more

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Weina LiuHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.ORCID 0000-0001-5377-9714
Fengyun YuHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-5607-1102
Pascal GeldsetzerHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-8878-5505
Juntao YangChinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID 0000-0003-1180-391X
Zhuoran WangChinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID 0000-0001-5175-8645
Todd GoldenNational Cancer Institute Division of Cancer Control and Population Sciences, Rockville, Maryland, USA.
Lirui JiaoMailman School of Public Health, Columbia University, New York City, New York, USA.ORCID 0000-0002-2505-7447
Qiushi ChenHarold and Inge Marcus Department of Industrial and Manufacturing Engineering, The Pennsylvania State University, University Park, Pennsylvania, USA.ORCID 0000-0003-4031-2669
Haitao LiuChinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID 0000-0002-6184-1466
Peixin WuChinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID 0000-0002-1288-0610
Chen WangChinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID 0000-0001-7857-5435
Till BärnighausenInstitute of Public Health, Universitatsklinikum Heidelberg Institut fur Global Health, Heidelberg, Germany.ORCID 0000-0002-4182-4212
Simiao ChenHeidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany simiao.chen@uni-heidelberg.de.ORCID 0000-0003-0555-2157

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe aimed to determine (1) the prevalence of depression during the COVID-19 pandemic among Chinese adults and (2) how depression prevalence varied by province and sociodemographic characteristics.

designCross-sectional study.

settingNational online survey in China.

participantsWe conducted a cross-sectional online survey among adults registered with the survey company KuRunData from 8 May 2020 to 8 June 2020. We aimed to recruit 300-360 adults per province (n=14 493), with a similar distribution by sex and rural-urban residency as the general population within each of these provinces. PRIMARY OUTCOME: Participants completed the Patient Health Questionaire-9 (PHQ-9). We calculated the prevalence of depression (defined as a PHQ-9 score ≥10) nationally and separately for each province. ANALYSIS: Covariate-unadjusted and covariate-adjusted logistic regression models were used to examine how the prevalence of depression varied by adults' sociodemographic characteristics. All analyses used survey sampling weights.

resultsThe survey was initiated by 14 493 participants, with 10 000 completing all survey questions and included in the analysis. The prevalence of depression in the national sample was 6.3% (95% CI 5.7% to 6.8%). A higher odds of depression was associated with living in an urban area (OR 1.50; 95% CI 1.18 to 1.90) and working as a nurse (OR 3.06; 95% CI 1.41 to 6.66). A lower odds of depression was associated with participants who had accurate knowledge of COVID-19 transmission prevention actions (OR 0.71; 95% CI 0.51 to 0.98), the knowledge that saliva is a main transmission route (OR 0.80; 95% CI 0.64 to 0.99) and awareness of COVID-19 symptoms (OR, 0.82; 95% CI 0.68 to 1.00).

conclusionAround one in 20 adults in our online survey sample had a PHQ-9 score suggestive of depression. Interventions and policies to prevent and treat depression during the COVID-19 pandemic in China may be particularly needed for nurses and those living in urban areas.

Indexed as

COVID-19AdultAnxietyChinaCross-Sectional StudiesDepressionHumansPandemicsPrevalenceSARS-CoV-2Surveys and QuestionnairesCOVID-19epidemiologymental health

Identifiers

PMID35264364
PMCPMC8914405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.